Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 11/20 | 0.55 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5161 | 0.78 | ALOX5 (0.59) | ALOX5HTR2BHTR7GAANPSR1 | |
| SCHEMBL1664428 | 0.77 | ALOX5 (0.53) | ALOX5HTR2BHTR7GAANPSR1 | |
| SCHEMBL28032699 | 0.76 | ALOX5 (0.57) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL5808288 | 0.76 | ALOX5 (0.94) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL27849240 | 0.74 | ALOX5 (0.90) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL28844098 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL6310178 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL29355714 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| Phenoxazine SCHEMBL7862 | 0.73 | ALOX5 (1.00) | ALOX5HTR2BHTR7GAANPSR1 | |
| SCHEMBL15062387 | 0.73 | ALOX5 (0.52) | ALOX5HTR2BHTR7GAANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3931176-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | Firmenich SA (CH) | 2022-01-05 | — | — | EP | claimed |
| WO-2021023627-A1 | HYDROGENATION OF IMINES WITH RU COMPLEXES | FIRMENICH SA (CH) | 2021-02-11 | — | — | WO | claimed |
| EP-2159244-B1 | ANTHRACENE POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2016-11-23 | — | — | EP | claimed |
| US-8513877-B2 | Anthracene polymer compound and light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-20 | — | — | US | claimed |
| US-20110284829-A1 | POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-24 | — | — | US | claimed |
| US-20100156284-A1 | ANTHRACENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2010-06-24 | — | — | US | claimed |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-05-06 | — | — | US | claimed |
| EP-2159244-A1 | ANTHRACENE POLYMER COMPOUND AND LIGHT-EMITTING DEVICE USING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-03-03 | — | — | EP | claimed |
| EP-2147944-A1 | PYRENE POLYMER AND LUMINESCENT ELEMENT MADE WITH THE SAME | Sumitomo Chemical Company, Limited (JP) | 2010-01-27 | — | — | EP | claimed |
| US-20240197888-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. | 2024-06-20 | — | — | US | disclosed |
| US-20240190885-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240190883-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | BIOTHERYX, INC. (US) | 2024-06-13 | — | — | US | disclosed |
| WO-2024120466-A1 | MONOSACCARIDES, PHARMACEUTICAL COMPOSITIONS, AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | SURIO THERAPEUTICS CO., LTD (CN) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024120442-A1 | PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) | 2024-06-13 | — | — | WO | disclosed |
| US-20080075882-A1 | PROCESS FOR PRODUCING MOLDED PRINTED MATERIAL, AND MOLDED PRINTED MATERIAL | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-6051722-A | PRECURSOR FOR POLYIMIDE COPOLYMER; USABLE IN OPTICAL LONG-DISTANCE COMMUNICATION, SIGNAL PROCESSING, PHOTOELECTRIC HYBRID CIRCUITS AND OPTICAL COMPUTERS | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2000-04-18 | — | — | US | disclosed |
| US-5834575-A | POLYIMIDE OR POLYACRYLATE WITH PENDANT GROUP CONTAINING THIOPHENE RING, BENZENE RING AND VICINAL NITRILE GROUPS, SWITCHES FOR OPTICAL SIGNALS, COMMUNICATION TECHNOLOGY | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1998-11-10 | — | — | US | disclosed |
| US-5116708-A | HOLE TRANSPORTING MATERIAL | NIPPON OIL COMPANY, LIMITED (JP) | 1992-05-26 | — | — | US | disclosed |
| EP-0372979-A2 | Hole transporting material | NIPPON OIL COMPANY, LIMITED (JP) | 1990-06-13 | — | — | EP | disclosed |
| EP-0295084-A2 | Novel copolymers and electroactive polymers derived from same | NIPPON OIL CO. LTD. (JP) | 1988-12-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240190885-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | KRAS, NRAS, APC | ALOX5 4694/4885HTR2B 4588/4885HTR7 4641/4885 |
| US-20240197888-A1 | SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | SOS1, SOS2, SOST | ALOX5 4492/4885HTR2B 3917/4885HTR7 3949/4885 |
| US-20100109517-A1 | PYRENE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | TERB1, AHR, CYP1A1 | ALOX5 2377/4885HTR2B 2335/4885HTR7 1917/4885 |
| US-20240190883-A1 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | KRAS, NRAS, APC | ALOX5 4685/4885HTR2B 4550/4885HTR7 4659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.